Скачать
Interim analysis of a Phase II study of the GLOVe regimen in untreated, high-risk MCL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-01-07
Просмотров: 21
Описание:
Tycel Phillips, MD, City of Hope, Duarte, CA, shares the interim analysis of the Phase II study of glofitamab, lenalidomide, and venetoclax (GLOVe) in untreated patients with high-risk mantle cell lymphoma (MCL). Dr Phillips highlights that the analysis shows promising responses, as well as a manageable safety profile. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
